hccinfhir 0.2.8__tar.gz → 0.2.9__tar.gz
This diff represents the content of publicly available package versions that have been released to one of the supported registries. The information contained in this diff is provided for informational purposes only and reflects changes between package versions as they appear in their respective public registries.
- {hccinfhir-0.2.8 → hccinfhir-0.2.9}/PKG-INFO +91 -1
- {hccinfhir-0.2.8 → hccinfhir-0.2.9}/README.md +90 -0
- hccinfhir-0.2.9/hccinfhir/data/ra_dx_edits.csv +108 -0
- hccinfhir-0.2.9/hccinfhir/data/ra_proposed_coefficients_2027.csv +3722 -0
- {hccinfhir-0.2.8 → hccinfhir-0.2.9}/hccinfhir/datamodels.py +6 -2
- {hccinfhir-0.2.8 → hccinfhir-0.2.9}/hccinfhir/defaults.py +4 -1
- {hccinfhir-0.2.8 → hccinfhir-0.2.9}/hccinfhir/model_calculate.py +8 -1
- hccinfhir-0.2.9/hccinfhir/model_edits.py +108 -0
- {hccinfhir-0.2.8 → hccinfhir-0.2.9}/hccinfhir/utils.py +79 -3
- {hccinfhir-0.2.8 → hccinfhir-0.2.9}/pyproject.toml +1 -1
- {hccinfhir-0.2.8 → hccinfhir-0.2.9}/.gitignore +0 -0
- {hccinfhir-0.2.8 → hccinfhir-0.2.9}/LICENSE +0 -0
- {hccinfhir-0.2.8 → hccinfhir-0.2.9}/hccinfhir/__init__.py +0 -0
- {hccinfhir-0.2.8 → hccinfhir-0.2.9}/hccinfhir/constants.py +0 -0
- {hccinfhir-0.2.8 → hccinfhir-0.2.9}/hccinfhir/data/__init__.py +0 -0
- {hccinfhir-0.2.8 → hccinfhir-0.2.9}/hccinfhir/data/hcc_is_chronic.csv +0 -0
- {hccinfhir-0.2.8 → hccinfhir-0.2.9}/hccinfhir/data/hcc_is_chronic_without_esrd_model.csv +0 -0
- {hccinfhir-0.2.8 → hccinfhir-0.2.9}/hccinfhir/data/ph_race_and_ethnicity_cdc_v1.3.csv +0 -0
- {hccinfhir-0.2.8 → hccinfhir-0.2.9}/hccinfhir/data/ra_coefficients_2025.csv +0 -0
- {hccinfhir-0.2.8 → hccinfhir-0.2.9}/hccinfhir/data/ra_coefficients_2026.csv +0 -0
- {hccinfhir-0.2.8 → hccinfhir-0.2.9}/hccinfhir/data/ra_dx_to_cc_2025.csv +0 -0
- {hccinfhir-0.2.8 → hccinfhir-0.2.9}/hccinfhir/data/ra_dx_to_cc_2026.csv +0 -0
- {hccinfhir-0.2.8 → hccinfhir-0.2.9}/hccinfhir/data/ra_eligible_cpt_hcpcs_2023.csv +0 -0
- {hccinfhir-0.2.8 → hccinfhir-0.2.9}/hccinfhir/data/ra_eligible_cpt_hcpcs_2024.csv +0 -0
- {hccinfhir-0.2.8 → hccinfhir-0.2.9}/hccinfhir/data/ra_eligible_cpt_hcpcs_2025.csv +0 -0
- {hccinfhir-0.2.8 → hccinfhir-0.2.9}/hccinfhir/data/ra_eligible_cpt_hcpcs_2026.csv +0 -0
- {hccinfhir-0.2.8 → hccinfhir-0.2.9}/hccinfhir/data/ra_hierarchies_2025.csv +0 -0
- {hccinfhir-0.2.8 → hccinfhir-0.2.9}/hccinfhir/data/ra_hierarchies_2026.csv +0 -0
- {hccinfhir-0.2.8 → hccinfhir-0.2.9}/hccinfhir/data/ra_labels_2026.csv +0 -0
- {hccinfhir-0.2.8 → hccinfhir-0.2.9}/hccinfhir/extractor.py +0 -0
- {hccinfhir-0.2.8 → hccinfhir-0.2.9}/hccinfhir/extractor_834.py +0 -0
- {hccinfhir-0.2.8 → hccinfhir-0.2.9}/hccinfhir/extractor_837.py +0 -0
- {hccinfhir-0.2.8 → hccinfhir-0.2.9}/hccinfhir/extractor_fhir.py +0 -0
- {hccinfhir-0.2.8 → hccinfhir-0.2.9}/hccinfhir/filter.py +0 -0
- {hccinfhir-0.2.8 → hccinfhir-0.2.9}/hccinfhir/hccinfhir.py +0 -0
- {hccinfhir-0.2.8 → hccinfhir-0.2.9}/hccinfhir/model_coefficients.py +0 -0
- {hccinfhir-0.2.8 → hccinfhir-0.2.9}/hccinfhir/model_demographics.py +0 -0
- {hccinfhir-0.2.8 → hccinfhir-0.2.9}/hccinfhir/model_dx_to_cc.py +0 -0
- {hccinfhir-0.2.8 → hccinfhir-0.2.9}/hccinfhir/model_hierarchies.py +0 -0
- {hccinfhir-0.2.8 → hccinfhir-0.2.9}/hccinfhir/model_interactions.py +0 -0
- {hccinfhir-0.2.8 → hccinfhir-0.2.9}/hccinfhir/sample_files/__init__.py +0 -0
- {hccinfhir-0.2.8 → hccinfhir-0.2.9}/hccinfhir/sample_files/sample_834_01.txt +0 -0
- {hccinfhir-0.2.8 → hccinfhir-0.2.9}/hccinfhir/sample_files/sample_834_02.txt +0 -0
- {hccinfhir-0.2.8 → hccinfhir-0.2.9}/hccinfhir/sample_files/sample_834_03.txt +0 -0
- {hccinfhir-0.2.8 → hccinfhir-0.2.9}/hccinfhir/sample_files/sample_834_04.txt +0 -0
- {hccinfhir-0.2.8 → hccinfhir-0.2.9}/hccinfhir/sample_files/sample_834_05.txt +0 -0
- {hccinfhir-0.2.8 → hccinfhir-0.2.9}/hccinfhir/sample_files/sample_834_06.txt +0 -0
- {hccinfhir-0.2.8 → hccinfhir-0.2.9}/hccinfhir/sample_files/sample_837_0.txt +0 -0
- {hccinfhir-0.2.8 → hccinfhir-0.2.9}/hccinfhir/sample_files/sample_837_1.txt +0 -0
- {hccinfhir-0.2.8 → hccinfhir-0.2.9}/hccinfhir/sample_files/sample_837_10.txt +0 -0
- {hccinfhir-0.2.8 → hccinfhir-0.2.9}/hccinfhir/sample_files/sample_837_11.txt +0 -0
- {hccinfhir-0.2.8 → hccinfhir-0.2.9}/hccinfhir/sample_files/sample_837_12.txt +0 -0
- {hccinfhir-0.2.8 → hccinfhir-0.2.9}/hccinfhir/sample_files/sample_837_2.txt +0 -0
- {hccinfhir-0.2.8 → hccinfhir-0.2.9}/hccinfhir/sample_files/sample_837_3.txt +0 -0
- {hccinfhir-0.2.8 → hccinfhir-0.2.9}/hccinfhir/sample_files/sample_837_4.txt +0 -0
- {hccinfhir-0.2.8 → hccinfhir-0.2.9}/hccinfhir/sample_files/sample_837_5.txt +0 -0
- {hccinfhir-0.2.8 → hccinfhir-0.2.9}/hccinfhir/sample_files/sample_837_6.txt +0 -0
- {hccinfhir-0.2.8 → hccinfhir-0.2.9}/hccinfhir/sample_files/sample_837_7.txt +0 -0
- {hccinfhir-0.2.8 → hccinfhir-0.2.9}/hccinfhir/sample_files/sample_837_8.txt +0 -0
- {hccinfhir-0.2.8 → hccinfhir-0.2.9}/hccinfhir/sample_files/sample_837_9.txt +0 -0
- {hccinfhir-0.2.8 → hccinfhir-0.2.9}/hccinfhir/sample_files/sample_eob_1.json +0 -0
- {hccinfhir-0.2.8 → hccinfhir-0.2.9}/hccinfhir/sample_files/sample_eob_2.json +0 -0
- {hccinfhir-0.2.8 → hccinfhir-0.2.9}/hccinfhir/sample_files/sample_eob_200.ndjson +0 -0
- {hccinfhir-0.2.8 → hccinfhir-0.2.9}/hccinfhir/sample_files/sample_eob_3.json +0 -0
- {hccinfhir-0.2.8 → hccinfhir-0.2.9}/hccinfhir/samples.py +0 -0
|
@@ -1,6 +1,6 @@
|
|
|
1
1
|
Metadata-Version: 2.3
|
|
2
2
|
Name: hccinfhir
|
|
3
|
-
Version: 0.2.
|
|
3
|
+
Version: 0.2.9
|
|
4
4
|
Summary: HCC Algorithm for FHIR Resources
|
|
5
5
|
Project-URL: Homepage, https://github.com/mimilabs/hccinfhir
|
|
6
6
|
Project-URL: Issues, https://github.com/mimilabs/hccinfhir/issues
|
|
@@ -408,6 +408,96 @@ if result.interactions:
|
|
|
408
408
|
| `"CMS-HCC ESRD Model V21"` | 2024-2025 | ESRD populations | ✅ |
|
|
409
409
|
| `"CMS-HCC ESRD Model V24"` | 2025-2026 | ESRD populations | ✅ |
|
|
410
410
|
| `"RxHCC Model V08"` | 2024-2026 | Part D prescription drug | ✅ |
|
|
411
|
+
| `"RxHCC Model V08 PDP_AND_MAPD"` | 2027 (proposed) | Part D - Combined reference estimate | ✅ |
|
|
412
|
+
| `"RxHCC Model V08 PDP_ONLY"` | 2027 (proposed) | Part D - Standalone PDP plans | ✅ |
|
|
413
|
+
| `"RxHCC Model V08 MAPD_ONLY"` | 2027 (proposed) | Part D - MA-PD plans | ✅ |
|
|
414
|
+
|
|
415
|
+
### Using Proposed 2027 Coefficients
|
|
416
|
+
|
|
417
|
+
The library includes proposed CMS coefficients for 2027 payment year (`ra_proposed_coefficients_2027.csv`). These are useful for:
|
|
418
|
+
- **Prospective planning**: Estimate future RAF scores before final rates are published
|
|
419
|
+
- **Impact analysis**: Compare current vs. proposed coefficient changes
|
|
420
|
+
- **Research**: Model different payment scenarios
|
|
421
|
+
|
|
422
|
+
```python
|
|
423
|
+
from hccinfhir import HCCInFHIR, Demographics
|
|
424
|
+
|
|
425
|
+
# CMS-HCC with proposed 2027 coefficients
|
|
426
|
+
processor_2027 = HCCInFHIR(
|
|
427
|
+
model_name="CMS-HCC Model V28",
|
|
428
|
+
coefficients_filename="ra_proposed_coefficients_2027.csv"
|
|
429
|
+
)
|
|
430
|
+
|
|
431
|
+
demographics = Demographics(age=70, sex="M", dual_elgbl_cd="00")
|
|
432
|
+
diagnosis_codes = ["E11.9", "I10", "N18.3"]
|
|
433
|
+
|
|
434
|
+
result = processor_2027.calculate_from_diagnosis(diagnosis_codes, demographics)
|
|
435
|
+
print(f"2027 Proposed RAF Score: {result.risk_score:.3f}")
|
|
436
|
+
```
|
|
437
|
+
|
|
438
|
+
**RxHCC Plan-Specific Variants**
|
|
439
|
+
|
|
440
|
+
CMS is introducing plan-specific RxHCC coefficients for 2027, separating standalone PDP and MA-PD plans. The combined PDP_AND_MAPD estimate is also provided as a traditional reference:
|
|
441
|
+
|
|
442
|
+
```python
|
|
443
|
+
# PDP and MA-PD combined (traditional reference estimate)
|
|
444
|
+
processor_pdp_mapd = HCCInFHIR(
|
|
445
|
+
model_name="RxHCC Model V08 PDP_AND_MAPD",
|
|
446
|
+
coefficients_filename="ra_proposed_coefficients_2027.csv"
|
|
447
|
+
)
|
|
448
|
+
|
|
449
|
+
# PDP-only plans (standalone Part D)
|
|
450
|
+
processor_pdp = HCCInFHIR(
|
|
451
|
+
model_name="RxHCC Model V08 PDP_ONLY",
|
|
452
|
+
coefficients_filename="ra_proposed_coefficients_2027.csv"
|
|
453
|
+
)
|
|
454
|
+
|
|
455
|
+
# MA-PD only plans (Medicare Advantage with Part D)
|
|
456
|
+
processor_mapd = HCCInFHIR(
|
|
457
|
+
model_name="RxHCC Model V08 MAPD_ONLY",
|
|
458
|
+
coefficients_filename="ra_proposed_coefficients_2027.csv"
|
|
459
|
+
)
|
|
460
|
+
|
|
461
|
+
# Compare scores across plan types
|
|
462
|
+
demographics = Demographics(age=70, sex="F", low_income=True)
|
|
463
|
+
diagnosis_codes = ["E11.9"]
|
|
464
|
+
|
|
465
|
+
for name, proc in [("PDP_AND_MAPD", processor_pdp_mapd),
|
|
466
|
+
("PDP_ONLY", processor_pdp),
|
|
467
|
+
("MAPD_ONLY", processor_mapd)]:
|
|
468
|
+
result = proc.calculate_from_diagnosis(diagnosis_codes, demographics)
|
|
469
|
+
print(f"{name}: {result.risk_score:.3f}")
|
|
470
|
+
```
|
|
471
|
+
|
|
472
|
+
**Comparing 2026 vs 2027 Coefficients**
|
|
473
|
+
|
|
474
|
+
```python
|
|
475
|
+
from hccinfhir import HCCInFHIR, Demographics
|
|
476
|
+
|
|
477
|
+
# Current 2026 coefficients
|
|
478
|
+
processor_2026 = HCCInFHIR(
|
|
479
|
+
model_name="CMS-HCC Model V28",
|
|
480
|
+
coefficients_filename="ra_coefficients_2026.csv"
|
|
481
|
+
)
|
|
482
|
+
|
|
483
|
+
# Proposed 2027 coefficients
|
|
484
|
+
processor_2027 = HCCInFHIR(
|
|
485
|
+
model_name="CMS-HCC Model V28",
|
|
486
|
+
coefficients_filename="ra_proposed_coefficients_2027.csv"
|
|
487
|
+
)
|
|
488
|
+
|
|
489
|
+
demographics = Demographics(age=70, sex="M", dual_elgbl_cd="00")
|
|
490
|
+
diagnosis_codes = ["E11.9", "I10", "N18.3"]
|
|
491
|
+
|
|
492
|
+
result_2026 = processor_2026.calculate_from_diagnosis(diagnosis_codes, demographics)
|
|
493
|
+
result_2027 = processor_2027.calculate_from_diagnosis(diagnosis_codes, demographics)
|
|
494
|
+
|
|
495
|
+
print(f"2026 RAF Score: {result_2026.risk_score:.3f}")
|
|
496
|
+
print(f"2027 RAF Score: {result_2027.risk_score:.3f}")
|
|
497
|
+
print(f"Change: {((result_2027.risk_score / result_2026.risk_score) - 1) * 100:.1f}%")
|
|
498
|
+
```
|
|
499
|
+
|
|
500
|
+
> **Note**: Proposed coefficients are subject to change. Always verify against final CMS publications for payment calculations.
|
|
411
501
|
|
|
412
502
|
### Custom Data Files
|
|
413
503
|
|
|
@@ -393,6 +393,96 @@ if result.interactions:
|
|
|
393
393
|
| `"CMS-HCC ESRD Model V21"` | 2024-2025 | ESRD populations | ✅ |
|
|
394
394
|
| `"CMS-HCC ESRD Model V24"` | 2025-2026 | ESRD populations | ✅ |
|
|
395
395
|
| `"RxHCC Model V08"` | 2024-2026 | Part D prescription drug | ✅ |
|
|
396
|
+
| `"RxHCC Model V08 PDP_AND_MAPD"` | 2027 (proposed) | Part D - Combined reference estimate | ✅ |
|
|
397
|
+
| `"RxHCC Model V08 PDP_ONLY"` | 2027 (proposed) | Part D - Standalone PDP plans | ✅ |
|
|
398
|
+
| `"RxHCC Model V08 MAPD_ONLY"` | 2027 (proposed) | Part D - MA-PD plans | ✅ |
|
|
399
|
+
|
|
400
|
+
### Using Proposed 2027 Coefficients
|
|
401
|
+
|
|
402
|
+
The library includes proposed CMS coefficients for 2027 payment year (`ra_proposed_coefficients_2027.csv`). These are useful for:
|
|
403
|
+
- **Prospective planning**: Estimate future RAF scores before final rates are published
|
|
404
|
+
- **Impact analysis**: Compare current vs. proposed coefficient changes
|
|
405
|
+
- **Research**: Model different payment scenarios
|
|
406
|
+
|
|
407
|
+
```python
|
|
408
|
+
from hccinfhir import HCCInFHIR, Demographics
|
|
409
|
+
|
|
410
|
+
# CMS-HCC with proposed 2027 coefficients
|
|
411
|
+
processor_2027 = HCCInFHIR(
|
|
412
|
+
model_name="CMS-HCC Model V28",
|
|
413
|
+
coefficients_filename="ra_proposed_coefficients_2027.csv"
|
|
414
|
+
)
|
|
415
|
+
|
|
416
|
+
demographics = Demographics(age=70, sex="M", dual_elgbl_cd="00")
|
|
417
|
+
diagnosis_codes = ["E11.9", "I10", "N18.3"]
|
|
418
|
+
|
|
419
|
+
result = processor_2027.calculate_from_diagnosis(diagnosis_codes, demographics)
|
|
420
|
+
print(f"2027 Proposed RAF Score: {result.risk_score:.3f}")
|
|
421
|
+
```
|
|
422
|
+
|
|
423
|
+
**RxHCC Plan-Specific Variants**
|
|
424
|
+
|
|
425
|
+
CMS is introducing plan-specific RxHCC coefficients for 2027, separating standalone PDP and MA-PD plans. The combined PDP_AND_MAPD estimate is also provided as a traditional reference:
|
|
426
|
+
|
|
427
|
+
```python
|
|
428
|
+
# PDP and MA-PD combined (traditional reference estimate)
|
|
429
|
+
processor_pdp_mapd = HCCInFHIR(
|
|
430
|
+
model_name="RxHCC Model V08 PDP_AND_MAPD",
|
|
431
|
+
coefficients_filename="ra_proposed_coefficients_2027.csv"
|
|
432
|
+
)
|
|
433
|
+
|
|
434
|
+
# PDP-only plans (standalone Part D)
|
|
435
|
+
processor_pdp = HCCInFHIR(
|
|
436
|
+
model_name="RxHCC Model V08 PDP_ONLY",
|
|
437
|
+
coefficients_filename="ra_proposed_coefficients_2027.csv"
|
|
438
|
+
)
|
|
439
|
+
|
|
440
|
+
# MA-PD only plans (Medicare Advantage with Part D)
|
|
441
|
+
processor_mapd = HCCInFHIR(
|
|
442
|
+
model_name="RxHCC Model V08 MAPD_ONLY",
|
|
443
|
+
coefficients_filename="ra_proposed_coefficients_2027.csv"
|
|
444
|
+
)
|
|
445
|
+
|
|
446
|
+
# Compare scores across plan types
|
|
447
|
+
demographics = Demographics(age=70, sex="F", low_income=True)
|
|
448
|
+
diagnosis_codes = ["E11.9"]
|
|
449
|
+
|
|
450
|
+
for name, proc in [("PDP_AND_MAPD", processor_pdp_mapd),
|
|
451
|
+
("PDP_ONLY", processor_pdp),
|
|
452
|
+
("MAPD_ONLY", processor_mapd)]:
|
|
453
|
+
result = proc.calculate_from_diagnosis(diagnosis_codes, demographics)
|
|
454
|
+
print(f"{name}: {result.risk_score:.3f}")
|
|
455
|
+
```
|
|
456
|
+
|
|
457
|
+
**Comparing 2026 vs 2027 Coefficients**
|
|
458
|
+
|
|
459
|
+
```python
|
|
460
|
+
from hccinfhir import HCCInFHIR, Demographics
|
|
461
|
+
|
|
462
|
+
# Current 2026 coefficients
|
|
463
|
+
processor_2026 = HCCInFHIR(
|
|
464
|
+
model_name="CMS-HCC Model V28",
|
|
465
|
+
coefficients_filename="ra_coefficients_2026.csv"
|
|
466
|
+
)
|
|
467
|
+
|
|
468
|
+
# Proposed 2027 coefficients
|
|
469
|
+
processor_2027 = HCCInFHIR(
|
|
470
|
+
model_name="CMS-HCC Model V28",
|
|
471
|
+
coefficients_filename="ra_proposed_coefficients_2027.csv"
|
|
472
|
+
)
|
|
473
|
+
|
|
474
|
+
demographics = Demographics(age=70, sex="M", dual_elgbl_cd="00")
|
|
475
|
+
diagnosis_codes = ["E11.9", "I10", "N18.3"]
|
|
476
|
+
|
|
477
|
+
result_2026 = processor_2026.calculate_from_diagnosis(diagnosis_codes, demographics)
|
|
478
|
+
result_2027 = processor_2027.calculate_from_diagnosis(diagnosis_codes, demographics)
|
|
479
|
+
|
|
480
|
+
print(f"2026 RAF Score: {result_2026.risk_score:.3f}")
|
|
481
|
+
print(f"2027 RAF Score: {result_2027.risk_score:.3f}")
|
|
482
|
+
print(f"Change: {((result_2027.risk_score / result_2026.risk_score) - 1) * 100:.1f}%")
|
|
483
|
+
```
|
|
484
|
+
|
|
485
|
+
> **Note**: Proposed coefficients are subject to change. Always verify against final CMS publications for payment calculations.
|
|
396
486
|
|
|
397
487
|
### Custom Data Files
|
|
398
488
|
|
|
@@ -0,0 +1,108 @@
|
|
|
1
|
+
icd10,edit_type,sex,age_min,age_max,action,cc_override,model_name,description
|
|
2
|
+
D66,sex,2,,,override,112,CMS-HCC Model V28,Hemophilia A in female - assign to CC 112
|
|
3
|
+
D67,sex,2,,,override,112,CMS-HCC Model V28,Hemophilia B in female - assign to CC 112
|
|
4
|
+
J410,age,,,17,invalid,,CMS-HCC Model V28,Simple chronic bronchitis - invalid if age < 18
|
|
5
|
+
J411,age,,,17,invalid,,CMS-HCC Model V28,Mucopurulent chronic bronchitis - invalid if age < 18
|
|
6
|
+
J418,age,,,17,invalid,,CMS-HCC Model V28,Mixed chronic bronchitis - invalid if age < 18
|
|
7
|
+
J42,age,,,17,invalid,,CMS-HCC Model V28,Unspecified chronic bronchitis - invalid if age < 18
|
|
8
|
+
J430,age,,,17,invalid,,CMS-HCC Model V28,Unilateral pulmonary emphysema - invalid if age < 18
|
|
9
|
+
J431,age,,,17,invalid,,CMS-HCC Model V28,Panlobular emphysema - invalid if age < 18
|
|
10
|
+
J432,age,,,17,invalid,,CMS-HCC Model V28,Centrilobular emphysema - invalid if age < 18
|
|
11
|
+
J438,age,,,17,invalid,,CMS-HCC Model V28,Other emphysema - invalid if age < 18
|
|
12
|
+
J439,age,,,17,invalid,,CMS-HCC Model V28,Emphysema unspecified - invalid if age < 18
|
|
13
|
+
J440,age,,,17,invalid,,CMS-HCC Model V28,COPD with acute lower respiratory infection - invalid if age < 18
|
|
14
|
+
J441,age,,,17,invalid,,CMS-HCC Model V28,COPD with acute exacerbation - invalid if age < 18
|
|
15
|
+
J449,age,,,17,invalid,,CMS-HCC Model V28,COPD unspecified - invalid if age < 18
|
|
16
|
+
J982,age,,,17,invalid,,CMS-HCC Model V28,Interstitial emphysema - invalid if age < 18
|
|
17
|
+
J983,age,,,17,invalid,,CMS-HCC Model V28,Compensatory emphysema - invalid if age < 18
|
|
18
|
+
J4481,age,,,17,invalid,,CMS-HCC Model V28,Bronchiolitis obliterans - invalid if age < 18
|
|
19
|
+
J4489,age,,,17,invalid,,CMS-HCC Model V28,Other specified COPD - invalid if age < 18
|
|
20
|
+
C50011,age,,,49,override,22,CMS-HCC Model V28,Breast cancer nipple right female - bypass MCE if age < 50
|
|
21
|
+
C50012,age,,,49,override,22,CMS-HCC Model V28,Breast cancer nipple left female - bypass MCE if age < 50
|
|
22
|
+
C50019,age,,,49,override,22,CMS-HCC Model V28,Breast cancer nipple unspecified female - bypass MCE if age < 50
|
|
23
|
+
C50021,age,,,49,override,22,CMS-HCC Model V28,Breast cancer nipple right male - bypass MCE if age < 50
|
|
24
|
+
C50022,age,,,49,override,22,CMS-HCC Model V28,Breast cancer nipple left male - bypass MCE if age < 50
|
|
25
|
+
C50029,age,,,49,override,22,CMS-HCC Model V28,Breast cancer nipple unspecified male - bypass MCE if age < 50
|
|
26
|
+
C50111,age,,,49,override,22,CMS-HCC Model V28,Breast cancer central portion right female - bypass MCE if age < 50
|
|
27
|
+
C50112,age,,,49,override,22,CMS-HCC Model V28,Breast cancer central portion left female - bypass MCE if age < 50
|
|
28
|
+
C50119,age,,,49,override,22,CMS-HCC Model V28,Breast cancer central portion unspecified female - bypass MCE if age < 50
|
|
29
|
+
C50121,age,,,49,override,22,CMS-HCC Model V28,Breast cancer central portion right male - bypass MCE if age < 50
|
|
30
|
+
C50122,age,,,49,override,22,CMS-HCC Model V28,Breast cancer central portion left male - bypass MCE if age < 50
|
|
31
|
+
C50129,age,,,49,override,22,CMS-HCC Model V28,Breast cancer central portion unspecified male - bypass MCE if age < 50
|
|
32
|
+
C50211,age,,,49,override,22,CMS-HCC Model V28,Breast cancer upper-inner quadrant right female - bypass MCE if age < 50
|
|
33
|
+
C50212,age,,,49,override,22,CMS-HCC Model V28,Breast cancer upper-inner quadrant left female - bypass MCE if age < 50
|
|
34
|
+
C50219,age,,,49,override,22,CMS-HCC Model V28,Breast cancer upper-inner quadrant unspecified female - bypass MCE if age < 50
|
|
35
|
+
C50221,age,,,49,override,22,CMS-HCC Model V28,Breast cancer upper-inner quadrant right male - bypass MCE if age < 50
|
|
36
|
+
C50222,age,,,49,override,22,CMS-HCC Model V28,Breast cancer upper-inner quadrant left male - bypass MCE if age < 50
|
|
37
|
+
C50229,age,,,49,override,22,CMS-HCC Model V28,Breast cancer upper-inner quadrant unspecified male - bypass MCE if age < 50
|
|
38
|
+
C50311,age,,,49,override,22,CMS-HCC Model V28,Breast cancer lower-inner quadrant right female - bypass MCE if age < 50
|
|
39
|
+
C50312,age,,,49,override,22,CMS-HCC Model V28,Breast cancer lower-inner quadrant left female - bypass MCE if age < 50
|
|
40
|
+
C50319,age,,,49,override,22,CMS-HCC Model V28,Breast cancer lower-inner quadrant unspecified female - bypass MCE if age < 50
|
|
41
|
+
C50321,age,,,49,override,22,CMS-HCC Model V28,Breast cancer lower-inner quadrant right male - bypass MCE if age < 50
|
|
42
|
+
C50322,age,,,49,override,22,CMS-HCC Model V28,Breast cancer lower-inner quadrant left male - bypass MCE if age < 50
|
|
43
|
+
C50329,age,,,49,override,22,CMS-HCC Model V28,Breast cancer lower-inner quadrant unspecified male - bypass MCE if age < 50
|
|
44
|
+
C50411,age,,,49,override,22,CMS-HCC Model V28,Breast cancer upper-outer quadrant right female - bypass MCE if age < 50
|
|
45
|
+
C50412,age,,,49,override,22,CMS-HCC Model V28,Breast cancer upper-outer quadrant left female - bypass MCE if age < 50
|
|
46
|
+
C50419,age,,,49,override,22,CMS-HCC Model V28,Breast cancer upper-outer quadrant unspecified female - bypass MCE if age < 50
|
|
47
|
+
C50421,age,,,49,override,22,CMS-HCC Model V28,Breast cancer upper-outer quadrant right male - bypass MCE if age < 50
|
|
48
|
+
C50422,age,,,49,override,22,CMS-HCC Model V28,Breast cancer upper-outer quadrant left male - bypass MCE if age < 50
|
|
49
|
+
C50429,age,,,49,override,22,CMS-HCC Model V28,Breast cancer upper-outer quadrant unspecified male - bypass MCE if age < 50
|
|
50
|
+
C50511,age,,,49,override,22,CMS-HCC Model V28,Breast cancer lower-outer quadrant right female - bypass MCE if age < 50
|
|
51
|
+
C50512,age,,,49,override,22,CMS-HCC Model V28,Breast cancer lower-outer quadrant left female - bypass MCE if age < 50
|
|
52
|
+
C50519,age,,,49,override,22,CMS-HCC Model V28,Breast cancer lower-outer quadrant unspecified female - bypass MCE if age < 50
|
|
53
|
+
C50521,age,,,49,override,22,CMS-HCC Model V28,Breast cancer lower-outer quadrant right male - bypass MCE if age < 50
|
|
54
|
+
C50522,age,,,49,override,22,CMS-HCC Model V28,Breast cancer lower-outer quadrant left male - bypass MCE if age < 50
|
|
55
|
+
C50529,age,,,49,override,22,CMS-HCC Model V28,Breast cancer lower-outer quadrant unspecified male - bypass MCE if age < 50
|
|
56
|
+
C50611,age,,,49,override,22,CMS-HCC Model V28,Breast cancer axillary tail right female - bypass MCE if age < 50
|
|
57
|
+
C50612,age,,,49,override,22,CMS-HCC Model V28,Breast cancer axillary tail left female - bypass MCE if age < 50
|
|
58
|
+
C50619,age,,,49,override,22,CMS-HCC Model V28,Breast cancer axillary tail unspecified female - bypass MCE if age < 50
|
|
59
|
+
C50621,age,,,49,override,22,CMS-HCC Model V28,Breast cancer axillary tail right male - bypass MCE if age < 50
|
|
60
|
+
C50622,age,,,49,override,22,CMS-HCC Model V28,Breast cancer axillary tail left male - bypass MCE if age < 50
|
|
61
|
+
C50629,age,,,49,override,22,CMS-HCC Model V28,Breast cancer axillary tail unspecified male - bypass MCE if age < 50
|
|
62
|
+
C50811,age,,,49,override,22,CMS-HCC Model V28,Breast cancer overlapping sites right female - bypass MCE if age < 50
|
|
63
|
+
C50812,age,,,49,override,22,CMS-HCC Model V28,Breast cancer overlapping sites left female - bypass MCE if age < 50
|
|
64
|
+
C50819,age,,,49,override,22,CMS-HCC Model V28,Breast cancer overlapping sites unspecified female - bypass MCE if age < 50
|
|
65
|
+
C50821,age,,,49,override,22,CMS-HCC Model V28,Breast cancer overlapping sites right male - bypass MCE if age < 50
|
|
66
|
+
C50822,age,,,49,override,22,CMS-HCC Model V28,Breast cancer overlapping sites left male - bypass MCE if age < 50
|
|
67
|
+
C50829,age,,,49,override,22,CMS-HCC Model V28,Breast cancer overlapping sites unspecified male - bypass MCE if age < 50
|
|
68
|
+
C50911,age,,,49,override,22,CMS-HCC Model V28,Breast cancer unspecified site right female - bypass MCE if age < 50
|
|
69
|
+
C50912,age,,,49,override,22,CMS-HCC Model V28,Breast cancer unspecified site left female - bypass MCE if age < 50
|
|
70
|
+
C50919,age,,,49,override,22,CMS-HCC Model V28,Breast cancer unspecified site unspecified female - bypass MCE if age < 50
|
|
71
|
+
C50921,age,,,49,override,22,CMS-HCC Model V28,Breast cancer unspecified site right male - bypass MCE if age < 50
|
|
72
|
+
C50922,age,,,49,override,22,CMS-HCC Model V28,Breast cancer unspecified site left male - bypass MCE if age < 50
|
|
73
|
+
C50929,age,,,49,override,22,CMS-HCC Model V28,Breast cancer unspecified site unspecified male - bypass MCE if age < 50
|
|
74
|
+
C50A0,age,,,49,override,22,CMS-HCC Model V28,Breast cancer overlapping breast tissue unspecified - bypass MCE if age < 50
|
|
75
|
+
C50A1,age,,,49,override,22,CMS-HCC Model V28,Breast cancer overlapping breast tissue right - bypass MCE if age < 50
|
|
76
|
+
C50A2,age,,,49,override,22,CMS-HCC Model V28,Breast cancer overlapping breast tissue left - bypass MCE if age < 50
|
|
77
|
+
P040,age,,2,,invalid,,CMS-HCC Model V28,Fetus/newborn affected by maternal anesthesia - invalid if age >= 2
|
|
78
|
+
P041,age,,2,,invalid,,CMS-HCC Model V28,Fetus/newborn affected by other maternal medication - invalid if age >= 2
|
|
79
|
+
P0411,age,,2,,invalid,,CMS-HCC Model V28,Fetus/newborn affected by maternal antineoplastic chemotherapy - invalid if age >= 2
|
|
80
|
+
P0412,age,,2,,invalid,,CMS-HCC Model V28,Fetus/newborn affected by maternal cytotoxic drugs - invalid if age >= 2
|
|
81
|
+
P0413,age,,2,,invalid,,CMS-HCC Model V28,Fetus/newborn affected by maternal anticonvulsants - invalid if age >= 2
|
|
82
|
+
P0414,age,,2,,invalid,,CMS-HCC Model V28,Fetus/newborn affected by maternal opiates - invalid if age >= 2
|
|
83
|
+
P0415,age,,2,,invalid,,CMS-HCC Model V28,Fetus/newborn affected by maternal antidepressants - invalid if age >= 2
|
|
84
|
+
P0416,age,,2,,invalid,,CMS-HCC Model V28,Fetus/newborn affected by maternal amphetamines - invalid if age >= 2
|
|
85
|
+
P0417,age,,2,,invalid,,CMS-HCC Model V28,Fetus/newborn affected by maternal sedative-hypnotics - invalid if age >= 2
|
|
86
|
+
P0418,age,,2,,invalid,,CMS-HCC Model V28,Fetus/newborn affected by other maternal medication - invalid if age >= 2
|
|
87
|
+
P0419,age,,2,,invalid,,CMS-HCC Model V28,Fetus/newborn affected by maternal medication unspecified - invalid if age >= 2
|
|
88
|
+
P041A,age,,2,,invalid,,CMS-HCC Model V28,Fetus/newborn affected by maternal cannabis use - invalid if age >= 2
|
|
89
|
+
P042,age,,2,,invalid,,CMS-HCC Model V28,Fetus/newborn affected by maternal tobacco use - invalid if age >= 2
|
|
90
|
+
P043,age,,2,,invalid,,CMS-HCC Model V28,Fetus/newborn affected by maternal alcohol use - invalid if age >= 2
|
|
91
|
+
P0440,age,,2,,invalid,,CMS-HCC Model V28,Fetus/newborn affected by maternal cocaine use unspecified - invalid if age >= 2
|
|
92
|
+
P0441,age,,2,,invalid,,CMS-HCC Model V28,Fetus/newborn affected by maternal cocaine use - invalid if age >= 2
|
|
93
|
+
P0442,age,,2,,invalid,,CMS-HCC Model V28,Fetus/newborn affected by maternal crack cocaine use - invalid if age >= 2
|
|
94
|
+
P0449,age,,2,,invalid,,CMS-HCC Model V28,Fetus/newborn affected by maternal other drugs of addiction - invalid if age >= 2
|
|
95
|
+
P045,age,,2,,invalid,,CMS-HCC Model V28,Fetus/newborn affected by maternal chemical substances - invalid if age >= 2
|
|
96
|
+
P046,age,,2,,invalid,,CMS-HCC Model V28,Fetus/newborn affected by maternal radiation exposure - invalid if age >= 2
|
|
97
|
+
P048,age,,2,,invalid,,CMS-HCC Model V28,Fetus/newborn affected by other maternal noxious substances - invalid if age >= 2
|
|
98
|
+
P0481,age,,2,,invalid,,CMS-HCC Model V28,Fetus/newborn affected by maternal cannabis use - invalid if age >= 2
|
|
99
|
+
P0489,age,,2,,invalid,,CMS-HCC Model V28,Fetus/newborn affected by other maternal noxious substances - invalid if age >= 2
|
|
100
|
+
P049,age,,2,,invalid,,CMS-HCC Model V28,Fetus/newborn affected by maternal noxious substance unspecified - invalid if age >= 2
|
|
101
|
+
P270,age,,2,,invalid,,CMS-HCC Model V28,Wilson-Mikity syndrome - invalid if age >= 2
|
|
102
|
+
P271,age,,2,,invalid,,CMS-HCC Model V28,Bronchopulmonary dysplasia originating in perinatal period - invalid if age >= 2
|
|
103
|
+
P278,age,,2,,invalid,,CMS-HCC Model V28,Other chronic respiratory diseases originating in perinatal period - invalid if age >= 2
|
|
104
|
+
P279,age,,2,,invalid,,CMS-HCC Model V28,Unspecified chronic respiratory disease originating in perinatal period - invalid if age >= 2
|
|
105
|
+
P930,age,,2,,invalid,,CMS-HCC Model V28,Grey baby syndrome - invalid if age >= 2
|
|
106
|
+
P938,age,,2,,invalid,,CMS-HCC Model V28,Reactions/intoxications due to other drugs in newborn - invalid if age >= 2
|
|
107
|
+
P961,age,,2,,invalid,,CMS-HCC Model V28,Neonatal withdrawal symptoms from maternal therapeutic drugs - invalid if age >= 2
|
|
108
|
+
P962,age,,2,,invalid,,CMS-HCC Model V28,Withdrawal symptoms from therapeutic drugs in newborn - invalid if age >= 2
|